Company / Capital Expenditures
IGC Pharma, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$112.0K
FY2025
5-year range
$112.0K / $4.4M
FY2021-FY2025
Trend
-63.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $15,000 in FY2020 to $4M in FY2021.
Based on SEC 10-K filings.
$112,000 in FY2025 with a 5-year CAGR of +49.5%.
Declined from $236,000 to $112,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -57.6%
- 5-Year CAGR
- +49.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +49.5%, indicating consistent growth.
- In FY2025, capital expenditures decreased 63.9% year-over-year.
- Peak capital expenditures was recorded in FY2021.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $112.0K | -63.9% |
| FY2024 | $310.0K | +31.4% |
| FY2023 | $236.0K | -83.9% |
| FY2022 | $1.5M | -66.5% |
| FY2021 | $4.4M | +29160.0% |
| FY2020 | $15.0K | -89.0% |
| FY2019 | $136.0K | -6.6% |
| FY2018 | $145.7K | +19.2% |
| FY2017 | $122.2K | +59.7% |
| FY2016 | $76.5K | +801.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026